ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30
ASHLAND INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$71.19+0.04 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $3.27K
- P/E (TTM)
- –
- Dividend yield
- 2.30%
ASHLAND INC. revenue by segment
By business segment
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life Sciences [Member] | $180.00M | $172.00M | $139.00M | $173.00M | $162.00M | $172.00M | $134.00M | $193.00M | $195.00M | $222.00M | $200.00M | $203.00M | 36.2% | +11.1% |
| Personal Care [Member] | $155.00M | $150.00M | $123.00M | $151.00M | $147.00M | $146.00M | $134.00M | $161.00M | $175.00M | $169.00M | $129.00M | $146.00M | 31.2% | +5.4% |
| Personal Care [Member] | $155.00M | $150.00M | $123.00M | $151.00M | $147.00M | $146.00M | $134.00M | $161.00M | $175.00M | $169.00M | $129.00M | $146.00M | 31.2% | +5.4% |
| Specialty Additives [Member] | $136.00M | $134.00M | $102.00M | $131.00M | $131.00M | $134.00M | $115.00M | $143.00M | $150.00M | $157.00M | $122.00M | $144.00M | 27.4% | +3.8% |
| Intermediates [Member] | $37.00M | $35.00M | $31.00M | $33.00M | $33.00M | $37.00M | $33.00M | $36.00M | $36.00M | $40.00M | $33.00M | $37.00M | 7.4% | +12.1% |
| Intermediates [Member] | $37.00M | $35.00M | $31.00M | $33.00M | $33.00M | $37.00M | $33.00M | $36.00M | $36.00M | $40.00M | $33.00M | $37.00M | 7.4% | +12.1% |
| Operating income | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life Sciences [Member] | $45.00M | $35.00M | $17.00M | $39.00M | -$343.00M | $28.00M | $14.00M | $43.00M | $43.00M | $50.00M | $32.00M | $31.00M | -113.1% |
| Personal Care [Member] | $29.00M | $27.00M | $11.00M | $26.00M | $25.00M | $28.00M | $11.00M | $14.00M | $31.00M | $25.00M | $2.00M | $14.00M | +16.0% |
| Specialty Additives [Member] | $3.00M | -$7.00M | -$8.00M | $5.00M | -$345.00M | $7.00M | -$5.00M | $8.00M | $10.00M | -$18.00M | -$32.00M | -$12.00M | -100.9% |
| Intermediates [Member] | $3.00M | $4.00M | $0 | $2.00M | $4.00M | -$1.00M | $3.00M | $7.00M | $6.00M | $9.00M | $7.00M | $0 | -25.0% |
| Unallocated and Other [Member] | -$37.00M | -$20.00M | -$26.00M | -$11.00M | -$49.00M | -$11.00M | -$202.00M | -$41.00M | -$151.00M | -$45.00M | -$27.00M | -$43.00M | -24.5% |
By product or service
By region
From the segment and revenue-disaggregation notes of Ashland's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.